keratin.com, hair loss, baldness, alopecia, disease, and treatment information

why is there no loss of beard hair when using anti 5 alpha reductase, or anti androgen drugs ?

Hair Biology
Diagnosis / Decisions
Androgenetic Alopecia Biology
Androgenetic Alopecia Clinical Patterns
Androgenetic Alopecia Treatments
Hair Restoration
Alopecia Areata
Effluviums
Scarring Alopecias
Inflammatory Alopecias
Other Alopecias
Hair Shaft Defects
Infectious Hair Disease
Hirsutism / Hypertrichosis
Hair Color
Hair Cosmetics
Bits and Pieces
Immunology
Discussion Forums
Personal / Site Information


Why is there no loss of beard hair when using anti 5 alpha reductase, or anti androgen drugs

Hair follicles on different parts of the body have different responses to androgens. Scalp hair follicles miniaturise and become less active under androgen influence, especially dihydrotestosterone. In contrast, hair follicles in the pubic areas, and the beard in men, become larger and more active producing thick coarse hair under the influence of the exact same hormones. This might seem to suggest that antiandrogen drugs or any drug that reduces androgen levels near hair follicles, such as 5 alpha reductase inhibitors, may allow increased hair growth on the scalp but hair loss in the pubic and beard areas.

This does not happen - or does it? Comments made in conversation by scientists from Merck, the makers of Propecia, hinted that there may be some slight slow down in the rate of beard growth when using Propecia. Merck scientists claimed that individual dermatologists and some patients using Propecia had contacted the company with claims that they had reduced beard growth. However, none indicated actual beard hair loss.

The lack of complete beard and pubic hair loss is probably due to an apparent "point of no return" that hair follicles seem to pass through when we reach puberty. It seems that the first increase in hormones at puberty have a profound effect on determining the fate of hair follicles in adult life. Once hair follicles in the beard and pubic regions are switched into coarse hair production at puberty there is no going back. Equally, once scalp hair follicles are exposed to androgens in puberty their fate is sealed and the follicles are susceptible to male pattern baldness.

This is clearly demonstrated by some simple observations made when androgens were first identified as being important in pattern baldness. When men are castrated before puberty they never develop pattern baldness, even when there is a history of baldness in their families and even if they are given androgen hormone injections when they are adults. Equally these men have very little or no beard growth. Their public hair is usually in a female pattern and very sparse and there is no obvious increase in body hair growth after giving androgen injections.

In contrast, men castrated during or after puberty do not spontaneously develop pattern baldness, but if they are given androgen hormone injections pattern alopecia develops. They also have little beard growth but beards do develop if the men are given androgen injections.

Clearly the first exposure of hair follicles to androgens during puberty ensures a permanent switch occurs in androgen receptive hair follicles. Beard and pubic hair follicles are fated to grow thick coarse hair. Scalp hair follicles are made susceptible to androgenetic alopecia. Drastic changes in androgen levels in adult life may have minor effects on these hair follicles, but beard and pubic hair follicles cannot be completely switched off by reducing androgen hormone levels using drugs or otherwise.


Why is there no loss of beard hair when using anti 5 alpha reductase, or anti androgen drugs references

  • Public discussion at the 7th European Hair Research Society (EHRS) Meeting, York UK. 17th-19th September 1999
  • Hamilton JB. Effect of Castration in Adolescent and Young Adult Males Upon Further Changes in the Proportions of Bare and Hairy Scalp. J Clin Endocrinol Metab 1960; 20: 1309-14.
  • Ebling FJ. The biology of hair. Dermatol Clin. 1987 Jul;5(3):467-81.

Top of the page

Copyright ©. All Rights Reserved
http://www.keratin.com
Top of the page